ApprovalTrail

Company · Swiftwater, Pennsylvania, United States

Sanofi Pasteur Limited

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
2
0 authorized now
Natural health products
1
1 active licences
Medical device licences
0
0 active
Notices of Compliance
196

Drug products

Authorized products first.

NameDINStatus
FLUZONEStatus since Dec 201602365693Cancelled Pre Market
FLUZONEStatus since Dec 201602365715Cancelled Pre Market

Natural health products

Active licences first, newest first.

NameNPNStatus
Hand SanitizerLicensed Apr 202080098876Active

Notices of Compliance

Newest first.

  • BEYFORTUSMay 7, 2026 · NOC 37494 · Supplement to a New Drug Submission (SNDS)
  • BEYFORTUSApril 27, 2026 · NOC 37411 · Supplement to a New Drug Submission (SNDS)
  • MENQUADFIMarch 26, 2026 · NOC 37418 · Supplement to a New Drug Submission (SNDS)
  • PENTACELFebruary 20, 2026 · NOC 36951 · Supplement to a New Drug Submission (SNDS)
  • QUADRACELFebruary 20, 2026 · NOC 36952 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE; FLUZONE HIGH-DOSEAugust 21, 2025 · NOC 35882 · Supplement to a New Drug Submission (SNDS)
  • AVAXIMJuly 28, 2025 · NOC 35758 · Supplement to a New Drug Submission (SNDS)
  • IMOVAX POLIOJune 11, 2025 · NOC 35573 · Supplement to a New Drug Submission (SNDS)
  • AVAXIMMay 14, 2025 · NOC 35374 · Supplement to a New Drug Submission (SNDS)
  • TD ADSORBEDApril 2, 2025 · NOC 35109 · Supplement to a New Drug Submission (SNDS)
  • PENTACELMarch 24, 2025 · NOC 35068 · Supplement to a New Drug Submission (SNDS)
  • ACT-HIBMarch 24, 2025 · NOC 35069 · Supplement to a New Drug Submission (SNDS)
  • PENTACELMarch 21, 2025 · NOC 35065 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE; FLUZONE HIGH-DOSEFebruary 13, 2025 · NOC 34843 · Supplement to a New Drug Submission (SNDS)
  • FLUZONEDecember 5, 2024 · NOC 34515 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSEDecember 5, 2024 · NOC 34526 · Supplement to a New Drug Submission (SNDS)
  • MENQUADFIOctober 9, 2024 · NOC 34233 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENTSeptember 6, 2024 · NOC 33976 · Supplement to a New Drug Submission (SNDS)
  • MENQUADFIAugust 21, 2024 · NOC 33846 · Supplement to a New Drug Submission (SNDS)
  • BEYFORTUSAugust 13, 2024 · NOC 33814 · Supplement to a New Drug Submission (SNDS)
  • PENTACELJuly 9, 2024 · NOC 33602 · Supplement to a New Drug Submission (SNDS)
  • QUADRACELJuly 9, 2024 · NOC 33603 · Supplement to a New Drug Submission (SNDS)
  • IMOVAX RABIESJuly 2, 2024 · NOC 33556 · Supplement to a New Drug Submission (SNDS)
  • PANENZAJune 10, 2024 · NOC 33423 · Supplement to a New Drug Submission (SNDS)
  • FLUZONEMay 10, 2024 · NOC 33239 · New Drug Submission (NDS)
  • BEYFORTUSMarch 14, 2024 · NOC 32899 · New Drug Submission (NDS)
  • TYPHIM VIMarch 8, 2024 · NOC 32850 · Supplement to a New Drug Submission (SNDS)
  • AVAXIMFebruary 2, 2024 · NOC 32649 · Supplement to a New Drug Submission (SNDS)
  • ADACELNovember 30, 2023 · NOC 32215 · Supplement to a New Drug Submission (SNDS)
  • ADACEL-POLIONovember 6, 2023 · NOC 32041 · Supplement to a New Drug Submission (SNDS)
  • MENQUADFINovember 2, 2023 · NOC 32016 · Supplement to a New Drug Submission (SNDS)
  • IMOVAX POLIOOctober 30, 2023 · NOC 31975 · Supplement to a New Drug Submission (SNDS)
  • PANENZAOctober 27, 2023 · NOC 31953 · New Drug Submission (NDS)
  • FLUZONE QUADRIVALENT; FLUZONE® HIGH-DOSE QUADRIVALENTSeptember 13, 2023 · NOC 31615 · Supplement to a New Drug Submission (SNDS)
  • IMOVAX RABIESSeptember 6, 2023 · NOC 31568 · Supplement to a New Drug Submission (SNDS)
  • IMOVAX POLIOSeptember 6, 2023 · NOC 31569 · Supplement to a New Drug Submission (SNDS)
  • TD ADSORBEDJuly 7, 2023 · NOC 31153 · Supplement to a New Drug Submission (SNDS)
  • MENACTRAJune 6, 2023 · NOC 30965 · Supplement to a New Drug Submission (SNDS)
  • ADACELMay 11, 2023 · NOC 30690 · Supplement to a New Drug Submission (SNDS)
  • ACT-HIBMay 5, 2023 · NOC 30647 · Supplement to a New Drug Submission (SNDS)
  • PEDIACELApril 13, 2023 · NOC 30516 · Supplement to a New Drug Submission (SNDS)
  • SUPEMTEKApril 5, 2023 · NOC 30474 · Supplement to a New Drug Submission (SNDS)
  • ACT-HIBApril 4, 2023 · NOC 30456 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENTMarch 30, 2023 · NOC 30427 · Supplement to a New Drug Submission (SNDS)
  • QUADRACELJanuary 26, 2023 · NOC 30108 · Supplement to a New Drug Submission (SNDS)
  • PENTACELJanuary 26, 2023 · NOC 30109 · Supplement to a New Drug Submission (SNDS)
  • ADACELDecember 23, 2022 · NOC 29766 · Supplement to a New Drug Submission (SNDS)
  • ADACELNovember 14, 2022 · NOC 29466 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENTSeptember 12, 2022 · NOC 29001 · Supplement to a New Drug Submission (SNDS)
  • SUPEMTEKJuly 25, 2022 · NOC 28658 · Supplement to a New Drug Submission (SNDS)
  • TD ADSORBEDJuly 12, 2022 · NOC 28574 · Supplement to a New Drug Submission (SNDS)
  • TD ADSORBEDJune 14, 2022 · NOC 28466 · Supplement to a New Drug Submission (SNDS)
  • ADACEL-POLIOApril 29, 2022 · NOC 28049 · Supplement to a New Drug Submission (SNDS)
  • SUPEMTEKApril 19, 2022 · NOC 28031 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENTMarch 3, 2022 · NOC 27708 · Supplement to a New Drug Submission (SNDS)
  • ADACELDecember 15, 2021 · NOC 27247 · Supplement to a New Drug Submission (SNDS)
  • ADACEL-POLIOOctober 12, 2021 · NOC 26838 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENTSeptember 10, 2021 · NOC 26646 · Supplement to a New Drug Submission (SNDS)
  • TYPHIM VIJuly 6, 2021 · NOC 26228 · Supplement to a New Drug Submission (SNDS)
  • TYPHIM VIJune 15, 2021 · NOC 26084 · Supplement to a New Drug Submission (SNDS)
  • AVAXIMJune 2, 2021 · NOC 25979 · Supplement to a New Drug Submission (SNDS)
  • AVAXIM PEDIATRICMay 28, 2021 · NOC 25955 · Supplement to a New Drug Submission (SNDS)
  • IMOVAX RABIESMarch 22, 2021 · NOC 25506 · Supplement to a New Drug Submission (SNDS)
  • SUPEMTEKJanuary 14, 2021 · NOC 25019 · New Drug Submission (NDS)
  • MENQUADFIOctober 29, 2020 · NOC 24522 · New Drug Submission (NDS)
  • SMALLPOX VACCINE (FREEZE-DRIED)September 30, 2020 · NOC 24352 · Supplement to a New Drug Submission (SNDS)
  • ADACELSeptember 25, 2020 · NOC 24308 · Supplement to a New Drug Submission (SNDS)
  • ADACEL-POLIOSeptember 25, 2020 · NOC 24309 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSESeptember 15, 2020 · NOC 24240 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE QUADRIVALENTSeptember 15, 2020 · NOC 24245 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSE QUADRIVALENTJune 16, 2020 · NOC 23800 · Supplement to a New Drug Submission (SNDS)
  • PENTACELMay 5, 2020 · NOC 23553 · Supplement to a New Drug Submission (SNDS)
  • ADACEL-POLIOMay 5, 2020 · NOC 23554 · Supplement to a New Drug Submission (SNDS)
  • PEDIACELMay 5, 2020 · NOC 23555 · Supplement to a New Drug Submission (SNDS)
  • ADACELMay 5, 2020 · NOC 23556 · Supplement to a New Drug Submission (SNDS)
  • TRIPACELMay 5, 2020 · NOC 23557 · Supplement to a New Drug Submission (SNDS)
  • QUADRACELMay 5, 2020 · NOC 23558 · Supplement to a New Drug Submission (SNDS)
  • ACTACELMay 5, 2020 · NOC 23559 · Supplement to a New Drug Submission (SNDS)
  • IMOVAX RABIESOctober 15, 2019 · NOC 22778 · Supplement to a New Drug Submission (SNDS)
  • MENACTRASeptember 19, 2019 · NOC 22668 · Supplement to a New Drug Submission (SNDS)
  • YF-VAXSeptember 19, 2019 · NOC 22677 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSESeptember 11, 2019 · NOC 22634 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE QUADRIVALENTSeptember 11, 2019 · NOC 22635 · Supplement to a New Drug Submission (SNDS)
  • QUADRACELJuly 23, 2019 · NOC 22433 · Supplement to a New Drug Submission (SNDS)
  • PENTACELJuly 23, 2019 · NOC 22434 · Supplement to a New Drug Submission (SNDS)
  • AVAXIM PEDIATRICMarch 29, 2019 · NOC 22016 · Supplement to a New Drug Submission (SNDS)
  • VIVAXIMMarch 29, 2019 · NOC 22017 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE QUADRIVALENTFebruary 25, 2019 · NOC 21894 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH-DOSEFebruary 25, 2019 · NOC 21895 · Supplement to a New Drug Submission (SNDS)
  • YF-VAXDecember 21, 2018 · NOC 21646 · Supplement to a New Drug Submission (SNDS)
  • TYPHIM VIDecember 19, 2018 · NOC 21644 · Supplement to a New Drug Submission (SNDS)
  • TD ADSORBEDOctober 26, 2018 · NOC 21467 · Supplement to a New Drug Submission (SNDS)
  • PEDIACELOctober 26, 2018 · NOC 21468 · Supplement to a New Drug Submission (SNDS)
  • ADACELOctober 1, 2018 · NOC 21377 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE HIGH DOSESeptember 10, 2018 · NOC 21286 · Supplement to a New Drug Submission (SNDS)
  • FLUZONE QUADRIVALENTSeptember 10, 2018 · NOC 21287 · Supplement to a New Drug Submission (SNDS)
  • ACT-HIBJuly 20, 2018 · NOC 21107 · Supplement to a New Drug Submission (SNDS)
  • PENTACELJuly 20, 2018 · NOC 21108 · Supplement to a New Drug Submission (SNDS)
  • ACTACELJuly 20, 2018 · NOC 21109 · Supplement to a New Drug Submission (SNDS)
  • PEDIACELJuly 20, 2018 · NOC 21110 · Supplement to a New Drug Submission (SNDS)

The latest 100 of 196.